ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

FDA Panel Favors Device to Boost Lung Transplant Success

Saturday, March 22, 2014

Submitted by

Source

Author(s)

C Phend
On March 20, 2014, a panel of the FDA gave unanimous approval for use of an ex-vivo perfusion system for improving the quality of explanted lungs prior to transplantation. If this recommendation is followed by the FDA, such devices could be used clinically under IRB protocols.

Add comment

Log in or register to post comments